
#091: New treatment strategies in MS an ECTRIMS Special
This time, I will present some studies on new treatment options for MS that show promising results and were presented
This time, I will present some studies on new treatment options for MS that show promising results and were presented
iving with MS means coping with a complex mix of symptoms that can affect both physical and emotional well-being. These
Find out how the menopause affects MS. What new research reveals about progression, symptom management, biological aging and quality of life.
Rehabilitation for multiple sclerosis (MS) is rapidly evolving, with exciting new approaches tailored to the unique needs of people with
Hello and welcome to another summary of ECTRIMS 2024, this time on the topic of de-escalation and discontinuation of therapy.
Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
This year, ECTRIMS 2024 in Copenhagen, Denmark, will once again bring together leading experts in multiple sclerosis (MS) from around
Cladribine (Mavenclad, Leustat, Litak) is an induction therapy the supresses the immun system and is used for highly active MS.
I show you how to make the best of your life with MS from family to career to hobbies. Thanks to science and research, a lot is possible nowadays.
Then get 11 impulses for a positive course as a gift and receive important information about the disease.
Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.
Wait a moment!
Sign up for the newsletter now and get 11 tips on how you can positively influence your progress.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information